The Levels of the NMDA Receptor Co-Agonist D-Serine Are Reduced in the Substantia Nigra of MPTP-lesioned Macaques and in the Cerebrospinal Fluid of Parkinson’s Disease Patients

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-45419-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Morphometry of the Human Substantia Nigra in Ageing and Parkinson’s Disease

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2008English

Substantia Nigra Hyperechogenicity in Polish Patients With Parkinson’s Disease

Folia Morphologica
AnatomyHistology
2014English

Morphochemical Changes in the Substantia Nigra Cellular Structures in Parkinson’s Disease

Arkhiv Patologii
Forensic MedicinePathology
2017English

Effects of Chronic, Systemic Treatment With the Dopamine Receptor Agonist R-Apomorphine in Partially Lesioned Rat Model of Parkinson's Disease: An Electrophysiological Study of Substantia Nigra Dopamine Neurons

Chinese Journal of Physiology
Physiology
2011English

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease

ASN Neuro
NeuroscienceNeurology
2018English

The NMDA Receptor Co-Agonists, D-Serine and Glycine, Regulate Neuronal Dendritic Architecture in the Somatosensory Cortex

Neurobiology of Disease
Neurology
2012English

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2019English

Interleukin 4 and Interleukin 10 Levels Are Elevated in the Cerebrospinal Fluid of Patients With Creutzfeldt-Jakob Disease

Archives of Neurology
2005English

Crystal Structure of Serine Racemase That Produces Neurotransmitter D-Serine for Stimulation of the NMDA Receptor

Nihon Kessho Gakkaishi
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy